Menu Search
Equities

Delivra Health Brands Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
DHB:CVE

Delivra Health Brands Inc

Actions
  • Price (CAD)0.185
  • Today's Change0.005 / 2.78%
  • Shares traded29.77k
  • 1 Year change-7.50%
  • Beta0.6477
Data delayed at least 15 minutes, as of Feb 13 2026 19:34 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. It features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.

  • Revenue in CAD (TTM)13.41m
  • Net income in CAD-806.00k
  • Incorporated2008
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.